The National Lung Cancer Partnership’s 10th Annual Meeting is a half-day scientific symposium that will focus on the promises and challenges of transforming lung cancer research progress into longer, better lives for patients. Physicians, researchers, health care professionals, patients and advocates will come together to learn about the strides made and the obstacles that remain for improving diagnosis, treatment and patient care.

Dr. Matthew Meyerson of Dana-Farber Cancer Institute will deliver the meeting’s Keynote Address, The Cancer Genome Atlas: Searching for New Therapeutic Targets.

Interactive panel discussions, led by leaders in the lung cancer field, will focus on the future of genomic research and the implementation of lung cancer screening guidelines.

Treatment Opportunities Arising From Genomic Research
  •  Mapping the Genetic Landscape of Lung Cancer to Develop Next-Generation Therapies
  •  Considerations for Conducting and Interpreting Molecular Tests
  •  The Lung Cancer Mutation Consortium: Moving Molecularly Defined Therapy Up Front

Implementing Lung Cancer Screening in the Real World
  •  Communicating Guidelines: Who Should be Screened and When?
  •  Implementing Guidelines: Challenges and Potential Solutions for the Medical Community
  •  Perspectives on Shared Decision Making and Doctor-Patient Communication

This meeting will also feature highlights from recipients of the National Lung Cancer Partnership’s research grants.

Register Online

View the full agenda of the National Lung Cancer Partnership’s 2012 Annual Meeting.

Click here for Continuting Medical Education information and course details.

We would like to thank the following supporters for their educational grants:

Amgen
Astellas
Biodesix
Bristol-Myers Squibb
Celgene Corporation
Daiichi Sankyo, Inc.
Lilly USA, LLC
Morphotek, Inc.
Oncimmune, USA
Pfizer